Effect of buffer additives on solubilization and refolding of reteplase inclusion bodies

(2018) Effect of buffer additives on solubilization and refolding of reteplase inclusion bodies. Research in Pharmaceutical Sciences. pp. 413-421. ISSN 1735-5362

Full text not available from this repository.

Abstract

Reteplase is a non-glycosylated and recombinant form of tissue type plasminogen activator, which is produced in Escherichia coli. However, its overexpression usually leads to formation of inactive aggregates or inclusion bodies. In the present study, we report on the development of optimized processes for isolation, solubilization, and refolding of reteplase inclusion bodies to recover active protein. After protein overexpression in E. coli BL21 (DE3) inclusion bodies were isolated by cell disruption and repeated wash of pellet with buffer containing Triton X-100. To solubilize the inclusion bodies, different types, concentrations, pHs, and additives of denaturing agents were used. Rapid micro dilution method was applied for refolding of solubilized reteplase. Different chemical additives including sugars, alcohols, polymers, detergents, amino acids, kosmotropic, and chaotropic salts, reducing agents, and buffering agents were used in the refolding buffer. To evaluate the biological activity of refolded reteplase, an indirect chromogenic assay was performed. The best solubilizing agent for dissolving reteplase inclusion bodies was 6 M urea at pH 12. The optimized buffer for refolding of solubilized reteplase was found to be 1.15 M glucose, 9.16 mM imidazole, and 0.16 M sorbitol which resulted in high yield of biologically active protein. Our results indicate type, concentration, and pH of solvent and type, concentration, and combination of chemical additives can significantly influence the yield of inclusion bodies solubilization and refolding.

Item Type: Article
Keywords: chemical chaperone inclusion bodies refolding additives reteplase acute myocardial-infarction egg-white lysozyme escherichia-coli plasminogen-activator heart-disease protein mechanism trifluoroethanol renaturation expression
Divisions: Faculty of Pharmacy and Pharmaceutical Sciences > Department of Pharmaceutical Biotechnology
Isfahan Pharmaceutical Sciences Research center
Page Range: pp. 413-421
Journal or Publication Title: Research in Pharmaceutical Sciences
Journal Index: ISI
Volume: 13
Number: 5
Identification Number: https://doi.org/10.4103/1735-5362.236834
ISSN: 1735-5362
Depositing User: Zahra Otroj
URI: http://eprints.mui.ac.ir/id/eprint/6555

Actions (login required)

View Item View Item